TissueGene aims for $179m in Kosdaq float
US-based TissueGene has announced an indicative range for its Kosdaq listing of W202.5bn ($179.1m), with bookbuilding expected to start next month.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: